Drug Trial Radar · NCT07325292
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Jan 14, 2026
Primary completion
Jul 15, 2027
Study completion Nov 30, 2028
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jan 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, open-label, parallel, Phase 3 study with 2-arms for treatment. The purpose of this study is to evaluate SC administration of frexalimab every 4 weeks (q4w) compared to IV administration of frexalimab q4w in male and female participants with RMS and nrSPMS (aged 18 to 60 years at the time of enrollment). People diagnosed with MS are eligible for enrollment as long as they meet all the inclusion criteria and none of the exclusion criteria. Study details include: The study intervention duration will be 48 weeks (12 months) for Parts A and B combined. Optional Part C will last until the initiation of a long term safety study for Frexalimab.The follow up duration after the end of study intervention (in case of discontinuation) will be 6 months. The number of scheduled visits (Parts A and B) will be 17 for participants receiving frexalimab SC or IV, with an on-site visit frequency of every month between Week 4 and Week 24 in Part A, then every 1 to 3 months in Part B, then every 6 months in Part C. Participants discontinuing treatment before the End of Study will have an additional 3 follow-up visits.
Conditions
- Multiple Sclerosis
Interventions
FrexalimabDrug
Pharmaceutical form:Solution for injection-Route of administration:SC injection
FrexalimabDrug
Pharmaceutical form:Concentrate for solution for infusion-Route of administration:IV infusion
MRI contrast-enhancing preparationsDrug
Route of administration:IV injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under the curve over the interval W20 to W24(part A)Time frame: Until Week 24
- Trough concentration at steady state(part A)Time frame: Until Week 24
Locations
68 sites in 7 countries. Site status is shown where the registry gives one.
North Central Neurology Associates- Site Number : 8401100
Cullman, Alabama · Recruiting
Alabama Neurology Associates- Site Number : 8400115
Homewood, Alabama · Recruiting
Center for Neurology and Spine - Phoenix - East Bell Road- Site Number : 8400195
Phoenix, Arizona · Recruiting
Perseverance Research Center- Site Number : 8400138
Scottsdale, Arizona · Recruiting
Center for Neurosciences - Tucson- Site Number : 8400194
Tucson, Arizona · Recruiting
Chemidox Clinical Trials- Site Number : 8401157
Lancaster, California · Recruiting
Private Practice - Dr. Regina Berkovich- Site Number : 8400005
West Hollywood, California · Recruiting
Rocky Mountain Regional VA Medical Center- Site Number : 8400121
Aurora, Colorado · Recruiting
Advanced Neurology of Colorado- Site Number : 8400148
Fort Collins, Colorado · Recruiting
Neurology of Central Florida- Site Number : 8400147
Altamonte Springs, Florida · Recruiting
Norman Fixel Institute for Neurological Diseases (FIND)- Site Number : 8400054
Gainesville, Florida · Recruiting
Aqualane Clinical Research- Site Number : 8400026
Naples, Florida · Recruiting
Orlando Health Neuroscience Institute - Downtown Pavilion- Site Number : 8400060
Orlando, Florida · Recruiting
Neurology Associates of Ormond Beach- Site Number : 8400086
Ormond Beach, Florida · Recruiting
University of South Florida- Site Number : 8400013
Tampa, Florida · Recruiting
Palm Beach Neurology- Site Number : 8400105
West Palm Beach, Florida · Recruiting
Atlanta Neuroscience Institute- Site Number : 8400075
Atlanta, Georgia · Recruiting
Joi Life Wellness Group Llc- Site Number : 8400192
Smyrna, Georgia · Recruiting
Consultants in Neurology- Site Number : 8400020
Northbrook, Illinois · Recruiting
Baltimore Veterans Affairs Medical Center- Site Number : 8400163
Baltimore, Maryland · Recruiting
Neurology Center of New England- Site Number : 8400164
Foxborough, Massachusetts · Recruiting
Michigan Institute for Neurological Disorders- Site Number : 8400004
Farmington Hills, Michigan · Recruiting
Holy Name Medical Center- Site Number : 8400101
Teaneck, New Jersey · Recruiting
Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002
Charlotte, North Carolina · Recruiting
Raleigh Neurology Associates- Site Number : 8400014
Raleigh, North Carolina · Recruiting
The Ohio State University- Site Number : 8400009
Columbus, Ohio · Recruiting
The Boster Center for Multiple Sclerosis- Site Number : 8400006
Columbus, Ohio · Recruiting
Abington Neurological Associates- Site Number : 8401065
Abington, Pennsylvania · Recruiting
Hope Neurology- Site Number : 8400019
Knoxville, Tennessee · Recruiting
ANESC Research- Site Number : 8400187
El Paso, Texas · Recruiting
North Texas Institute of Neurology & Headache - Plano- Site Number : 8400082
Plano, Texas · Recruiting
North Texas Institute of Neurology & Headache - Plano- Site Number : 8400083
Plano, Texas · Recruiting
Neurology Center of San Antonio- Site Number : 8400099
San Antonio, Texas · Recruiting
Medical College of Wisconsin - Milwaukee Campus- Site Number : 8400038
Milwaukee, Wisconsin · Recruiting
Investigational Site Number : 0560001
Bruges, Belgium · Recruiting
Investigational Site Number : 0560008
Brussels, Belgium · Recruiting
Investigational Site Number : 0560006
Ghent, Belgium · Recruiting
Investigational Site Number : 0560007
Kortrijk, Belgium · Recruiting
Investigational Site Number : 0560005
Overpelt, Belgium · Recruiting
L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760003
Brasília, Federal District, Brazil · Recruiting
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.